Nirmala Sitharaman added that ‘Sabka Saath, Sabka Vikas’ is the third Kartavya of the government.
Finance Minister Nirmala Sitharaman on Sunday proposed Rs 10,000 crore investment in the biopharma sector over the next five years, a move which would give a boost to the country’s pharmaceuticals industry.
Biopharmaceuticals, or biologics, are complex medicines manufactured from living organisms, cells, or tissues rather than through chemical synthesis.
She also proposed interventions in six areas, including manufacturing, strategic and frontier sectors, healthcare and advanced technology.
The minister added that semiconductor mission 2.0 will focus on producing equipment and materials designed for full-stack Indian IP (intellectual property).
The India Semiconductor Mission (ISM) is a specialized, autonomous business division within Digital India Corporation under Ministry of Electronics and Information Technology (MeitY), designed to build a sustainable semiconductor and display ecosystem.
Sitharaman also announced support for mineral rich states of Odisha, Kerala, Andhra Pradesh and Tamil Nadu to establish critical mineral facilities.
She added that ‘Sabka Saath, Sabka Vikas’ is the third Kartavya of the government.
Budget 2026 Live Updates: Sitharaman Sets FY27 Capex Target At Rs 12.2 Lakh Crore; Rolls Out Schemes For MSMEs
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Comprehensive Budget 2026 coverage, LIVE TV analysis, Stock Market and Industry reactions, Income Tax changes and Latest News on NDTV Profit.
